1st Quarter - Report

MEHLMAN CONSULTING, INC. for BIOGEN IDEC INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate tax reform, Patent Box, and territorial tax system.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Health reform implementation issues. Independent Payment Advisory Board. Medicare Part D Rebate. Part B Reimbursement. Budget and entitlement reform.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans Pacific Partnership (TPP) trade agreement.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Health care reform implementation issues; follow on biologics. S. 1417 and H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1417 (113th), H.R. 1281 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.